Table of Contents Table of Contents
Previous Page  23 / 25 Next Page
Information
Show Menu
Previous Page 23 / 25 Next Page
Page Background

Page 78

conferenceseries

.com

Volume 8

Journal of Biotechnology & Biomaterials

ISSN: 2155-952X

Pharma Biotech 2018

December 10-11, 2018

December 10-11, 2018 | Rome, Italy

23

rd

International Conference on

Pharmaceutical Biotechnology

Optimization of fermentation conditions for extracellular production of a therapeutic protein drug

uricase, by

Aspergillus welwitschiae

using response surface methodology

Noura El-Ahmady El-Naggar

1

, S A Haroun

2

, Eman M El-Weshy

2

and

A A Sherief

2

1

Genetic Engineering and Biotechnology Research Institute, Egypt

2

Mansoura University, Egypt

U

ricase is commonly used in clinical analysis for the determination of urate in blood and other biological fluids. Microbial

uricases as protein drug have been found effective in the treatment of hyperuricemia and gout, as well as in prophylaxis

and treatment of tumor lysis hyperuricemia. A potential culture,

Aspergillus

sp. strain 1-4 displayed high extracellular

uricase activity. This uricolytic fungal isolate was identified as

Aspergillus welwitschiae

strain 1-4 on the basis of phenotypic

characteristics, together with ITS region sequence analysis. Sequencing product was deposited in the GenBank database under

accession number MG323529. The Plackett-Burman experimental design with 20 runs was applied for screening of fifteen

variables for their significances on uricase production by

Aspergillus welwitschiae

. Incubation time was the most significant

variable affecting uricase production followed by yeast extract and inoculum size with significant P-values of 0.0002, 0.0083 and

0.0118; respectively. These variables were chosen for optimization studies using central composite design. It was found that, the

maximum uricase production (59.01 U/mL) by

Aspergillus welwitschiae

is achieved at the following fermentation conditions

g/L: sucrose 30, uric acid 3, peptone 2, yeast extract 2, NaNO

3

2, K

2

HPO

4

1, MgSO

4

.7H

2

O 0.2, NaCl 0.2 and FeSO

4

.7H

2

O 0.03”,

incubation time 7 days, temperature 35, pH 6, inoculum size 4 mL/50 mL medium, inoculum age 72 h and medium volume

50 mL/250 mL conical flask. An overall 2.5-fold increase in uricase production by

Aspergillus welwitschiae

was achieved in

the medium after statistical optimization as compared with the unoptimized basal medium (23.58 U/mL) before applying

Plackett-Burman.

nouraelahmady@yahoo.com

J Biotechnol Biomater 2018, Volume 8

DOI: 10.4172/2155-952X-C8-110